Cargando…
Challenges in Detecting Clinically Relevant Heparin-Induced Thrombocytopenia Antibodies
Heparin-induced thrombocytopenia (HIT) is an antibody-mediated hypercoagulable state featuring high thrombosis risk and distinct pathogenesis involving immunoglobulin G-mediated platelet activation. The target of the immune response is a cationic “self” protein, platelet factor 4 (PF4), rendered ant...
Autor principal: | Warkentin, Theodore E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581458/ https://www.ncbi.nlm.nih.gov/pubmed/33091948 http://dx.doi.org/10.1055/a-1223-3329 |
Ejemplares similares
-
Autoimmune Heparin-Induced Thrombocytopenia
por: Warkentin, Theodore E.
Publicado: (2023) -
Heparin-induced thrombocytopenia
por: Jevtic, Stefan D., et al.
Publicado: (2021) -
Laboratory Testing for Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia Antibodies: A Narrative Review
por: Warkentin, Theodore E., et al.
Publicado: (2022) -
Limitations of the particle immunofiltration assay test for diagnosis of heparin‐induced thrombocytopenia
por: Warkentin, Theodore E., et al.
Publicado: (2020) -
Systematic review of fondaparinux for heparin‐induced thrombocytopenia: When there are no randomized controlled trials
por: Linkins, Lori‐Ann, et al.
Publicado: (2018)